1110 — Kingworld Medicines Balance Sheet
0.000.00%
Last trade - 00:00
- HK$336.15m
- HK$596.43m
- CNY1.08bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 129 | 261 | 198 | 256 | 194 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 369 | 297 | 280 | 237 | 277 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 734 | 715 | 640 | 624 | 589 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 178 | 168 | 210 | 300 | 386 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Total Assets | 1,280 | 1,255 | 1,214 | 1,263 | 1,338 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 576 | 556 | 474 | 542 | 464 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 677 | 664 | 597 | 648 | 719 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 603 | 592 | 617 | 616 | 619 |
Total Liabilities & Shareholders' Equity | 1,280 | 1,255 | 1,214 | 1,263 | 1,338 |
Total Common Shares Outstanding |